Journal Home
Search for

Volume 30, Issue 10, Pages 2192-2199 (October 2004)


View previous. 60 of 73 View next.

Expression of laminin-5 with amniotic membrane transplantation in excimer laser ablated rat corneas☆☆

Jun Haeng Lee, PhDCorresponding Author Informationaemail address, Hyung Keun Lee, MDa, Jin Kuk Kim, MD, PhDabcd, Jee Ho Chang, MDa, Sung Eun Kim, MDabcd, Eung Kweon Kim, MD,PhDabcd, Gong Je Seong, MDa, SoonWon Hong, MDc

Accepted 4 February 2004.

Abstract 

Purpose: To investigate the expression of laminin-5 during epithelial healing and evaluate its expression in vivo using rat corneas on which amniotic membrane was applied to cover the wound after excimer laser photoablation.

Setting: Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea.

Methods: Myopic photorefractive keratectomy (PRK) with a 100 μm deep ablation was performed in Sprague Dawley rats killed 6, 12, 24, 48, 72, and 96 hours after the procedure. In the first group of 30 rats, the excimer laser-ablated cornea was covered with amniotic membrane after PRK. Thirty other rats in which no amniotic membrane treatment was used served as controls. Immunohistochemical and immunofluorescein techniques were used to monitor the expression of laminin-5, γ2, and γ1 in the rat corneas. Immunoblotting was used to compare the expression of laminin between the amniotic membrane group and the control group.

Results: In the immunoblotting study, laminin-5, α3, and γ2 increased 24 hours after amniotic membrane treatment compared to the control group. At 12 hours, in vivo immunostaining of the corneas in both groups expressed laminin, but laminin-5 and γ2 were more intensely expressed in the amniotic membrane group. This continued until reepithelialization. Expression of the γ1 chain was not different between the 2 groups.

Conclusion: With the use of amniotic membrane, the expression of laminin-5 and γ2 was faster and more intense than in a control group during reepithelialization of excimer laser-ablated rat corneas.

a Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea

b Balgeunsesang Ophthalmology Clinic, Seoul, South Korea

c Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea

d Project of Brain Korea 21, Seoul, South Korea

Corresponding Author InformationReprint requests to Hyung Keun Lee, MD, Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea, 146-92 Yongdong Severance Hospital, Dogok-dong, Kangnam-gu, Seoul, Korea.

 Supported by a grant from the Korea Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea (02-PJ1-PG1-CH02-0003).

☆☆ None of the authors has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(04)00165-8

doi:10.1016/j.jcrs.2004.02.021


View previous. 60 of 73 View next.